|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

*
Liver Research Laboratories, Queen Elizabeth Hospital, Birmingham, United Kingdom; and
Department of Pathology, University of Birmingham Medical School, Birmingham, United Kingdom
T cell-mediated mechanisms are important in the defense against solid organ tumors. Why some tumors are more heavily infiltrated by T cells than others is poorly understood but is likely to depend upon adhesive interactions between circulating lymphocytes and tumor endothelium. In support of this hypothesis, the present study shows that primary human hepatocellular carcinomas (HCC) are more heavily infiltrated with T cells than colorectal hepatic metastases (CHM), and that their tumor vessels express high levels of several adhesion molecules. In HCC, an intense T cell infiltrate is observed within the tumor associated with strong expression of ICAM-1 and vascular adhesion protein-1 (VAP-1) on tumor endothelium. In contrast, fewer T cells infiltrated CHM and these tumors have little ICAM-1 and no detectable VAP-1 or VCAM-1 on tumor endothelium. T cells infiltrating both tumors are LFA-1 and very late Ag (VLA)-4 high. In vitro tissue-binding studies demonstrated that T cells bound readily to tumor endothelium in HCC, and Abs to ICAM-1, VAP-1, and to a lesser extent VCAM-1 could inhibit this binding. VAP-1 supported sialic acid-dependent adhesion under shear stress, suggesting that VAP-1 and ICAM-1 mediate, respectively, tethering and firm adhesion. In contrast, very few T cells bound to tumor vessels in CHM. Thus our data suggest that the VAP-1/VAP-1 receptor and ICAM-1/LFA-1 pathways are important in the recruitment of T cells to HCC. The strong expression of VAP-1 on tumor endothelium distinguishes HCC from CHM and supports our previous hypothesis that VAP-1 is an important hepatic endothelial adhesion molecule.
This article has been cited by other articles:
![]() |
F. Marttila-Ichihara, K. Auvinen, K. Elima, S. Jalkanen, and M. Salmi Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1+CD11b+ Myeloid Cells into Tumors Cancer Res., October 1, 2009; 69(19): 7875 - 7883. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Svensson, M. Hansson, J. Kilhamn, S. Backert, and M. Quiding-Jarbrink Selective Upregulation of Endothelial E-Selectin in Response to Helicobacter pylori-Induced Gastritis Infect. Immun., July 1, 2009; 77(7): 3109 - 3116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salmi and S. Jalkanen Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans Blood, September 1, 2006; 108(5): 1555 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawasuji, M. Hasegawa, M. Horikawa, T. Fujita, Y. Matsushita, T. Matsushita, M. Fujimoto, D. A. Steeber, T. F. Tedder, K. Takehara, et al. L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury J. Leukoc. Biol., April 1, 2006; 79(4): 696 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, W. Xu, Y. Chu, Y. Gong, Z. Jiang, and S. Xiong Involvement of Up-Regulated CXC Chemokine Ligand 16/Scavenger Receptor That Binds Phosphatidylserine and Oxidized Lipoprotein in Endotoxin-Induced Lethal Liver Injury via Regulation of T-Cell Recruitment and Adhesion Infect. Immun., July 1, 2005; 73(7): 4007 - 4016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dienst, A. Grunow, M. Unruh, B. Rabausch, J. E. Nor, J. W. U. Fries, and C. Gottstein Specific Occlusion of Murine and Human Tumor Vasculature by VCAM-1-Targeted Recombinant Fusion Proteins J Natl Cancer Inst, May 18, 2005; 97(10): 733 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Maula, M. Luukkaa, R. Grenman, D. Jackson, S. Jalkanen, and R. Ristamaki Intratumoral Lymphatics Are Essential for the Metastatic Spread and Prognosis in Squamous Cell Carcinomas of the Head and Neck Region Cancer Res., April 15, 2003; 63(8): 1920 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Lalor, S. Edwards, G. McNab, M. Salmi, S. Jalkanen, and D. H. Adams Vascular Adhesion Protein-1 Mediates Adhesion and Transmigration of Lymphocytes on Human Hepatic Endothelial Cells J. Immunol., July 15, 2002; 169(2): 983 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Grant, S. Goddard, J. Ahmed-Choudhury, G. Reynolds, D. G. Jackson, M. Briskin, L. Wu, S. G. Hubscher, and D. H. Adams Hepatic Expression of Secondary Lymphoid Chemokine (CCL21) Promotes the Development of Portal-Associated Lymphoid Tissue in Chronic Inflammatory Liver Disease Am. J. Pathol., April 1, 2002; 160(4): 1445 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Carlos Leukocyte recruitment at sites of tumor: dissonant orchestration J. Leukoc. Biol., August 1, 2001; 70(2): 171 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Irjala, M. Salmi, K. Alanen, R. Grenman, and S. Jalkanen Vascular Adhesion Protein 1 Mediates Binding of Immunotherapeutic Effector Cells to Tumor Endothelium J. Immunol., June 1, 2001; 166(11): 6937 - 6943. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Martelius, M. Salmi, H. Wu, C. Bruggeman, K. Hockerstedt, S. Jalkanen, and I. Lautenschlager Induction of Vascular Adhesion Protein-1 during Liver Allograft Rejection and Concomitant Cytomegalovirus Infection in Rats Am. J. Pathol., October 1, 2000; 157(4): 1229 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Alexander and D. N. Granger Lymphocyte Trafficking Mediated by Vascular Adhesion Protein-1 : Implications for Immune Targeting and Cardiovascular Disease Circ. Res., June 23, 2000; 86(12): 1190 - 1192. [Full Text] [PDF] |
||||
![]() |
Philip. L. Shields, C. M. Morland, M. Salmon, S. Qin, S. G. Hubscher, and D. H. Adams Chemokine and Chemokine Receptor Interactions Provide a Mechanism for Selective T Cell Recruitment to Specific Liver Compartments Within Hepatitis C-Infected Liver J. Immunol., December 1, 1999; 163(11): 6236 - 6243. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bono, S. Jalkanen, and M. Salmi Mouse Vascular Adhesion Protein 1 Is a Sialoglycoprotein with Enzymatic Activity and Is Induced in Diabetic Insulitis Am. J. Pathol., November 1, 1999; 155(5): 1613 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Yoong, S. C. Afford, S. Randhawa, S. G. Hubscher, and D. H. Adams Fas/Fas Ligand Interaction in Human Colorectal Hepatic Metastases : A Mechanism of Hepatocyte Destruction to Facilitate Local Tumor Invasion Am. J. Pathol., March 1, 1999; 154(3): 693 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Afford, S. Randhawa, A. G. Eliopoulos, S. G. Hubscher, L. S. Young, and D. H. Adams CD40 Activation Induces Apoptosis in Cultured Human Hepatocytes via Induction of Cell Surface Fas Ligand Expression and Amplifies Fas-mediated Hepatocyte Death during Allograft Rejection J. Exp. Med., January 18, 1999; 189(2): 441 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kurkijarvi, D. H. Adams, R. Leino, T. Mottonen, S. Jalkanen, and M. Salmi Circulating Form of Human Vascular Adhesion Protein-1 (VAP-1): Increased Serum Levels in Inflammatory Liver Diseases J. Immunol., August 1, 1998; 161(3): 1549 - 1557. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |